Cargando…

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

Detalles Bibliográficos
Autores principales: Friedli, Christoph, Diem, Lara, Hammer, Helly, Kamber, Nicole, Suter-Riniker, Franziska, Leib, Stephen, Chan, Andrew, Hirzel, Cédric, Hoepner, Robert, Salmen, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135211/
https://www.ncbi.nlm.nih.gov/pubmed/34046087
http://dx.doi.org/10.1177/17562864211016641
_version_ 1783695322407501824
author Friedli, Christoph
Diem, Lara
Hammer, Helly
Kamber, Nicole
Suter-Riniker, Franziska
Leib, Stephen
Chan, Andrew
Hirzel, Cédric
Hoepner, Robert
Salmen, Anke
author_facet Friedli, Christoph
Diem, Lara
Hammer, Helly
Kamber, Nicole
Suter-Riniker, Franziska
Leib, Stephen
Chan, Andrew
Hirzel, Cédric
Hoepner, Robert
Salmen, Anke
author_sort Friedli, Christoph
collection PubMed
description
format Online
Article
Text
id pubmed-8135211
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81352112021-05-26 Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies Friedli, Christoph Diem, Lara Hammer, Helly Kamber, Nicole Suter-Riniker, Franziska Leib, Stephen Chan, Andrew Hirzel, Cédric Hoepner, Robert Salmen, Anke Ther Adv Neurol Disord Letter to the Editor SAGE Publications 2021-05-18 /pmc/articles/PMC8135211/ /pubmed/34046087 http://dx.doi.org/10.1177/17562864211016641 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Friedli, Christoph
Diem, Lara
Hammer, Helly
Kamber, Nicole
Suter-Riniker, Franziska
Leib, Stephen
Chan, Andrew
Hirzel, Cédric
Hoepner, Robert
Salmen, Anke
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
title Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
title_full Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
title_fullStr Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
title_full_unstemmed Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
title_short Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
title_sort negative sars-cov2-antibodies after positive covid-19-pcr nasopharyngeal swab in patients treated with anti-cd20 therapies
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135211/
https://www.ncbi.nlm.nih.gov/pubmed/34046087
http://dx.doi.org/10.1177/17562864211016641
work_keys_str_mv AT friedlichristoph negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT diemlara negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT hammerhelly negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT kambernicole negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT suterrinikerfranziska negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT leibstephen negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT chanandrew negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT hirzelcedric negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT hoepnerrobert negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies
AT salmenanke negativesarscov2antibodiesafterpositivecovid19pcrnasopharyngealswabinpatientstreatedwithanticd20therapies